Physician profile
Pranav Barve
NPI 1972899839
$14,140.17
in general payments reported to CMS, 2019-2025
54 companies · $1,723 in 2025
The $1,723 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $1,216 · 2021: $2,966 · 2022: $2,709 · 2023: $2,480 · 2024: $2,325 · 2025: $1,723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,516 · Education: $12.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,515.81 |
| Education | $12.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,549.13 | 2021-2025 | Minimed 780g, Symplicity G3, Inpen Smart Insulin Delivery System |
| Abbvie INC. | $1,367.07 | 2020-2025 | Vraylar, Mavyret, Qulipta |
| Janssen Pharmaceuticals, INC | $1,155.41 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $1,091.40 | 2019-2025 | |
| Amgen INC. | $877.51 | 2020-2025 | Repatha, Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $848.18 | 2022-2025 | |
| Novo Nordisk INC | $817.01 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $727.85 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $500.92 | 2019-2024 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $383.30 | 2019-2025 | Lokelma, Breztri, Airsupra |
| Merck Sharp & Dohme LLC | $342.71 | 2021-2023 | Verquvo, Belsomra, Steglatro |
| Glaxosmithkline, LLC. | $341.69 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Corcept Therapeutics | $332.05 | 2020-2025 | Korlym |
| Otsuka America Pharmaceutical, INC. | $300.59 | 2023-2025 | Rexulti, Nuedexta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $287.25 | 2021-2025 | Jardiance, Tradjenta, Synjardy |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $270.93 | 2019-2021 | |
| Koya Medical, INC. | $232.67 | 2024 | Dayspring, Koya Medical |
| Astellas Pharma US INC | $225.59 | 2020-2025 | Veozah |
| Dexcom, INC. | $215.92 | 2024-2025 | Dexcom G6 Transmitter |
| Cvrx, INC. | $199.14 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $194.62 | 2023-2025 | Seglentis, Zoryve |
| Sumitomo Pharma America, INC. | $190.16 | 2024-2025 | Gemtesa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $177.71 | 2024-2025 | Caplyta |
| Lilly USA, LLC | $174.57 | 2020-2024 | Jardiance, Emgality, Mounjaro |
| Xeris Pharmaceuticals, INC. | $140.50 | 2022-2025 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $95.84 | 2019-2024 | Eliquis |
| Abbott Laboratories | $87.66 | 2021-2025 | Freestyle Libre 3, Id Now Instrument |
| Ucb, INC. | $86.54 | 2021-2022 | |
| Lundbeck LLC | $85.81 | 2024-2025 | Rexulti |
| Neurelis, INC. | $83.27 | 2023-2024 | Valtoco |
| Gilead Sciences, INC. | $79.75 | 2021-2023 | |
| Tactile Systems Technology INC | $73.34 | 2019-2022 | |
| Edwards Lifesciences Corporation | $63.99 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biohaven Pharmaceuticals, INC. | $47.47 | 2021 | |
| Corium, LLC | $46.62 | 2023 | Adlarity |
| Sanofi-Aventis U.S. LLC | $38.33 | 2019 | |
| Alpha Cognition USA, INC. | $37.98 | 2025 | Zunveyl |
| Exact Sciences Corporation | $31.86 | 2023-2025 | Cologuard Collection Kit |
| Medtronic Minimed, INC. | $30.65 | 2020 | |
| Medtronic Vascular, INC. | $29.39 | 2019 | |
| Alkermes, INC. | $29.38 | 2025 | Aristada, Lybalvi |
| Mycovia Pharmaceuticals, INC. | $29.17 | 2022 | |
| Zimmer Biomet Holdings, INC. | $29.11 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Hologic Sales and Service, LLC | $22.96 | 2024 | Thinprep 2000 Processor, Aptima |
| Biotronik INC. | $21.44 | 2021 | |
| Idorsia Pharmaceuticals US INC | $19.92 | 2023 | Quviviq |
| Biogen, INC. | $19.32 | 2024 | Zurzuvae |
| Almatica Pharma LLC | $18.78 | 2025 | Loreev Xr |
| Vertex Pharmaceuticals Incorporated | $18.76 | 2025 | |
| Scilex Pharmaceuticals INC. | $17.54 | 2019 | |
| Tms Neurohealth Centers INC. | $15.87 | 2025 | Tms Neurohealth Centers INC. |
| Tolmar, INC. | $15.27 | 2025 | Jatenzo |
| Phathom Pharmaceuticals, INC. | $14.27 | 2024 | Voquezna |
| Cequr Corporation | $6.00 | 2023 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pranav Barve listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.